Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome.
about
Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialPharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalitiesFactors related to continuous and discontinuous attendance at memory clinics.High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortexType 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach.Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease.Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Does metabolic syndrome impact cognition and emotion in Alzheimer's disease?Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity.Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction.Advances and insights into neurological practice 2016-17.Metabolic Syndrome and cognitive decline in the elderly: A systematic review.
P2860
Q29994589-BD23D97A-1254-47A8-A237-7A85F6ADB688Q34552380-91D56CFA-80DF-4365-8EE8-D14F715DFFDBQ38934118-92AB2D41-D3E3-4BF3-81CD-429B825759B7Q38937412-26B46613-EB04-48BB-9F54-81E883FB7E40Q42748376-85D0F5E8-8D40-4E5B-9F5E-508584349F96Q46184142-64ADBDDB-C06E-4162-8677-46F9B97A6BC5Q46245383-2D91DFC1-05E1-45DE-A934-B2C9D39ADAC7Q46646567-8190D5CB-2D75-4DFE-88EB-2F77F962FF51Q47408666-A6C5B370-36C6-46A9-8741-0C9D85BD0CA7Q47630615-84C957B4-6F2C-4A32-9152-B83334C93C4AQ47781003-27B32D11-7C1D-42C9-BB1F-D23EA25F5F8DQ48043052-083C7A9F-1865-49D7-8E68-55027DF7C5F6Q50072374-AA322B47-C38B-44FA-BA2A-AF0FA4A9A001Q54961329-B1FA2548-13C5-4A1C-AA12-F013BE97DA48
P2860
Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cognitive and affective functi ...... ients with metabolic syndrome.
@en
type
label
Cognitive and affective functi ...... ients with metabolic syndrome.
@en
prefLabel
Cognitive and affective functi ...... ients with metabolic syndrome.
@en
P2093
P2860
P356
P1476
Cognitive and affective functi ...... ients with metabolic syndrome.
@en
P2093
N Hishikawa
T Yamashita
P2860
P304
P356
10.1111/ENE.12845
P577
2015-10-23T00:00:00Z